Skip to main content

TÍTULO DEL ESTUDIO: OPEN-LABEL, MULTI-CENTRE, NON-INFERIORITY STUDY OF SAFETY AND IMMUNOGENICITY OF BIMERVAX® AS HETEROLOGOUS BOOSTER FOR THE PREVENTION OF CORONAVIRUS DISEASE 2019 (COVID-19) IN ADOLESCENTS FROM 12 YEARS TO LESS THAN 18 YEARS OF AGE.

Open
  • Protocol code: HIPRA-HH-3
  • EudraCT code: No aplica
  • Research group: Infection and Immunity in pediatric patients
  • Service: General Pediatrics and Specialties
  • Principal investigator:  Soler Palacín, Pere
  • Pathology: Certes malalties infeccioses i parasitàries
  • Phase: Fase II
  • Status: Recruiting volunteers